Analysis of miR-148b expression differences in stage-I and II parosteal osteosarcoma.

about

Analysis of miR-148b expression differences in stage-I and II parosteal osteosarcoma.

Item

http://www.wikidata.org/entity/Q55409382

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Analysis of miR-148b expression differences in stage-I and II parosteal osteosarcoma.

@en

Analysis of miR-148b expression differences in stage-I and II parosteal osteosarcoma.

@nl

type

Item

label

Analysis of miR-148b expression differences in stage-I and II parosteal osteosarcoma.

@en

Analysis of miR-148b expression differences in stage-I and II parosteal osteosarcoma.

@nl

prefLabel

Analysis of miR-148b expression differences in stage-I and II parosteal osteosarcoma.

@en

Analysis of miR-148b expression differences in stage-I and II parosteal osteosarcoma.

@nl

P1476

Analysis of miR-148b expression differences in stage-I and II parosteal osteosarcoma.

@en

P2093

Lu Wang

http://www.w3.org/2001/XMLSchema#string

Piji Chen

http://www.w3.org/2001/XMLSchema#string

Shengwu Yang

http://www.w3.org/2001/XMLSchema#string

Wenjun Lin

http://www.w3.org/2001/XMLSchema#string

Xin Chen

http://www.w3.org/2001/XMLSchema#string

Xiongbai Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma

MicroRNA-148b suppresses proliferation, migration, and invasion of nasopharyngeal carcinoma cells by targeting metastasis-associated gene 2

Osteosarcoma treatment - where do we stand? A state of the art review.

Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma.

A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile.

MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway.

MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival.

Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway.

miRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1.

P304

998-1002

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.8709

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29963175

http://www.w3.org/2001/XMLSchema#string

P932

6019924

http://www.w3.org/2001/XMLSchema#string